期刊文献+

血液净化方式对维持性透析患者晚期氧化蛋白产物的影响 被引量:3

下载PDF
导出
摘要 目的:观察血液透析方式对维持性透析(MHD)患者的晚期氧化蛋白产物(AOPP)分子水平清除的效果。方法:选择MHD患者单次血液灌流串联血液透析组(HP+HD组)60例,以及第7天行单纯血液透析组(HD组),单次血液透析滤过(HDF)60例,尿毒症未行血液透析(NHD)患者60例,健康对照组(CG)20例;检测血清中AOPP浓度。结果:①NHD、HD、HD+HP、HDF四组患者未治疗前血AOPP水平均高于CG(P<0.01);②HP+HD、HDF治疗后患者血AOPP水平较治疗前明显降低(P<0.01),HD组治疗后血AOPP水平均较治疗前明显升高(P<0.05);③单次HDF组治疗后血AOPP降低的水平较HP+HD组更有效,差异有显著性(P<0.01)。结论:HP+HD、HDF比单纯HD能更有效地降低MHD患者AOPP水平,单纯HD随着时间延长AOPP水平逐渐升高。HDF对大分子AOPP清除效率比HP更有效。
出处 《温州医学院学报》 CAS 2010年第1期74-76,共3页 Journal of Wenzhou Medical College
  • 相关文献

参考文献10

  • 1Santangelo F,Wit ko-Sarsat V, Drueke T, et al. Restoring glutat hione as a therapeutic strategy in chronic kidney disease[J] .Nephrol Dial Trans plant,2004,19 (8): 1951-1955.
  • 2Witko-Sarsat V, Friedlander M, Capeill re-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J]. Kidney Int,1996,49(5):1304- 1313.
  • 3Kalousova M, Zima T, Tesar V, et al. Advanced glycation end products and advanced oxidation protein products in hemedialyzed patients[J].Blood Purff,2002,20(6):531-536.
  • 4Descamps Latscha B, Jungers P, Witko Sarsat V. Immune system dysregulation in uremia: Role of oxidative stress[J]. Blood-PurifK,2002,20(5):481-484.
  • 5Descamps Latscha B,Drueke T, Witko Sarsat V. Dialysis- induced oxidative stress: Biological aspects, clinical consequences, and therapy[J].Semin Dial,2001,14(3):193- 199.
  • 6Witko Sarsat V, Gausson V, Descamps Latscha B. Are advanced oxidation protein products potential toxins?[J] .Kidney Int Suppl,2003,(84):S11-14.
  • 7WitkoSarsat V, Gausson V, Nguyen AT, et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism:a potential target for N-acetylcysteine treatment in dialysis patients[J].Kidney Int,2003,64:82-91.
  • 8刘俊,刘志强,陶惠琴.血液净化对慢性肾功能衰竭患者全段甲状旁腺激素的影响[J].第一军医大学学报,2004,24(2):234-235. 被引量:42
  • 9彭侃夫,吴雄飞,孙岩,王军霞,吴亿,孟建中.血液净化模式对尿毒症患者晚期氧化蛋白产物水平的影响[J].中国血液净化,2006,5(7):386-387. 被引量:5
  • 10陈朝生,徐玉兰,梅晓蓉,许菲菲,郑尘非,刘毅,王绿萍,黄朝兴.维持性血透患者进行高通量血透的临床研究[J].温州医学院学报,2007,37(3):267-270. 被引量:12

二级参考文献20

  • 1袁方,刘尚喜,侯凡凡,陈瑗,田建伟,刘志强.晚期氧化蛋白产物导致血管内皮细胞氧化应激损伤[J].解放军医学杂志,2004,29(11):951-954. 被引量:20
  • 2徐启河,刘平,李惊子,黄颖,冷炜,韩秀菊,申洪征.三种甲旁腺激素测定在血液透析患者的意义[J].北京医科大学学报,1994,26(4):287-288. 被引量:1
  • 3杨启菁,王梅.血液透析病人的氨基酸代谢变化及影响氨基酸丢失的因素[J].国外医学(泌尿系统分册),1996,16(3):128-130. 被引量:17
  • 4Descamps -Latscha B,Witko-Sarsat V.Importance of oxidatively modified proteins in chronic renal failure.Kidney Int,2001,78:S108
  • 5Drueke T,Witko Sarsat V,Massy ZA,et al.Iron therapy,advanced oxidation protein products,and carotid artery intima media thickness in end stage renal disease.Circulation,2002,106(17):2212
  • 6Kalousova M,Zima T,Tesar V,et al.Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients[J].Blood Purff,2002,20:531-536
  • 7Witko-Sarsat V,Friedllander M,Nguyen KT,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161(5):2524
  • 8Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.AmJ Kidney Dis,1998,32[SuPP13]:l12-119
  • 9Bostom AG,Lathrop L.HyPerhomocysteinemia in end-stage renal disease:Prevalence,etiology,and potential relationship to artherosclerotic outcomes.Kidney Int,1997,52:10-20
  • 10Ma KW,Greene EL,Reij L.Cardiovascular risk factors in chronic renal failure and hemodialysis Populations.Am J Kid Dis,1992,19:505-513

共引文献56

同被引文献42

  • 1Gideon Charach,Alexander Rabinovich,Ori Argov,Moshe Weintraub,Lior Charach,Oded Ayzenberg,Jacob George.Anti-oxidized low-density lipoprotein antibodies in chronic heart failure[J].World Journal of Cardiology,2012,4(11):302-308. 被引量:2
  • 2柏庆利,何国平.老年冠心病患者血中氧化修饰低密度脂蛋白抗体的表达[J].心脏杂志,2004,16(4):365-366. 被引量:1
  • 3彭侃夫,吴雄飞,孙岩,王军霞,吴亿,孟建中.血液净化模式对尿毒症患者晚期氧化蛋白产物水平的影响[J].中国血液净化,2006,5(7):386-387. 被引量:5
  • 4张智敏,吴凡,高爽,程圣英,周伟.尿毒症维持性血液透析患者不同透析龄血清氧化应激和炎症因子等指标的变化[J].中国误诊学杂志,2007,7(12):2681-2683. 被引量:2
  • 5Moriguchi R, Otaki Y, H azeki S, et al. High levels of tumor necrosis factor-a downregulate antimicrohial Iron transport protein, Nrampl, in chronic hemodialysis patients ; a key fac- tor for infection risk[J]. American Journal of Nephrology, 2012,35 (4) : 372-378.
  • 6Vaziri, Nosratola D,Navab, Kaveh,Gollapudi, Pavan,Moradi, Hamid,Pahl, Madeleine V,Barton, Cyril H,Fogelman, Alan M,Navab, Mohamad.Salutary Effects of Hemodialysis on Low-Density Lipoprotein Proinflammatory and High-Density Lipoprotein Anti-inflammatory Properties in Patient With End-Stage Renal Disease[J].Journal of the National Medical Association.2011(6)
  • 7P. R. Krishnaswamy,Anjali Rao,W. Murali,H. Sudarshan Ballal.Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy[J].Indian Journal of Clinical Biochemistry.2006(2)
  • 8Nolan CR. Strategies for improving long-term survivalin pa-tients with ESRD[J]. J Am Soc Nephrol, 2005,16(11 Suppl2); S120-S127.
  • 9Stenvinkel P, Heimbrger 0,Paultre F, et al. Strong associa-tion between malnutrition, inflammation, and atherosclerosisin chronic renal failure [J]. Kidney Int,1999,55(5): 1899-1911.
  • 10Raj DS,Dominic EA, Pai A, et al. Skeletal muscle, cyto-kines? and oxidative stress in end-stage renal disease[J]. Kid-ney Int, 2005,68(5): 2338-2344.

引证文献3

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部